Cocrystal Pharma (COCP) Assets Average (2011 - 2026)
Cocrystal Pharma (COCP) posted Assets Average of $8.6 million for Q1 2026, down 14.98% sequentially from $10.1 million in Q4 2025, and down 28.93% YoY from $12.1 million in Q1 2025.
Cocrystal Pharma (COCP) Assets Average (2011 - 2026) Analysis & Trends
Cocrystal Pharma has reported Assets Average for 14 years, with the latest figure at $8.6 million in Q1 2026.
- Quarterly Assets Average fell 28.93% year-over-year to $8.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 million (down 28.93% YoY) and the FY2025 annual result came in at $11.6 million, down 48.19% from the prior year.
- Assets Average retreated to $8.6 million in Q1 2026 per COCP's latest filing, from $10.1 million in the prior quarter.
- Over five years, Assets Average peaked at $77.4 million in Q1 2022 and troughed at $8.6 million in Q1 2026.
- A 5-year average of $30.2 million and a median of $28.9 million in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2022 and 2025: Assets Average surged 43.18% in 2022, then sank 60.17% in 2025.
- Over 5 years, Assets Average stood at $43.2 million in 2022, then decreased by 26.15% to $31.9 million in 2023, then plunged by 53.52% to $14.8 million in 2024, then slumped by 32.1% to $10.1 million in 2025, then fell by 14.98% to $8.6 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $8.6 million, $10.1 million, and $9.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn | 5.34 Bn |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn | 25.27 Bn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 2.09 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 19.82 Bn |
| 10 | Cocrystal Pharma | 16.27 Mn | 13.95 Mn | - | 6.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.04 Mn |
| Mar 31, 2026 | 8.57 Mn |
| Dec 31, 2025 | 10.08 Mn |
| Sep 30, 2025 | 9.48 Mn |
| Jun 30, 2025 | 9.58 Mn |
| Mar 31, 2025 | 12.06 Mn |
| Dec 31, 2024 | 14.84 Mn |
| Sep 30, 2024 | 18.90 Mn |
| Jun 30, 2024 | 24.06 Mn |
| Mar 31, 2024 | 28.90 Mn |
| Dec 31, 2023 | 31.94 Mn |
| Sep 30, 2023 | 34.45 Mn |
| Jun 30, 2023 | 37.06 Mn |
| Mar 31, 2023 | 39.34 Mn |
| Dec 31, 2022 | 43.24 Mn |
| Sep 30, 2022 | 49.02 Mn |
| Jun 30, 2022 | 63.88 Mn |
| Mar 31, 2022 | 77.38 Mn |
| Dec 31, 2021 | 81.00 Mn |
| Sep 30, 2021 | 85.01 Mn |